Nasal corticosteroids market to reach $9.87 billion by 2030 at 8.0% cagr, driven by increasing prevalence of respiratory diseases and allergic conditions.
Read More
Messenger ribonucleic acid (mrna) synthesis and manufacturing market to reach $9.22 billion by 2030 at 12.3% CAGR, driven by increasing prevalence of infectious diseases.
Read More
Narcotic drugs market to reach $18.79 billion by 2030 at 5.2% cagr, driven by rising incidence of chronic diseases requiring long-term pain management.
Read More
Messenger ribonucleic acid (mrna) capping enzyme market to reach $1.97 billion by 2030 at 14.1% CAGR, driven by growing adoption of personalized medicine.
Read More
Nanotechnology based medical devices market to reach $23.24 billion by 2030 at 36.9% cagr, driven by increasing adoption of personalized medicine and precision healthcare tools.
Read More
Men’s health supplements market to reach $148.91 billion by 2030 at 11.4% CAGR, driven by increase in disposable income.
Read More
Nanopharmaceuticals market to reach $254.37 billion by 2030 at 17.7% cagr, driven by rising prevalence of chronic diseases and need for advanced therapeutic options.
Read More
Menopause supplement market to reach $2.98 billion by 2030 at 7.7% CAGR, driven by rising prevalence of menopausal symptoms.
Read More
Nanomedicine drug delivery market to reach $252.69 billion by 2030 at 15.4% cagr, driven by growing adoption of personalized medicine and targeted drug delivery systems.
Read More
Menopausal disorder treatment market to reach $16.26 billion by 2030 at 7.2% CAGR, driven by rising demand for hormone replacement therapies.
Read More